CN115429839A - A Chinese medicinal composition - Google Patents
A Chinese medicinal composition Download PDFInfo
- Publication number
- CN115429839A CN115429839A CN202211227606.XA CN202211227606A CN115429839A CN 115429839 A CN115429839 A CN 115429839A CN 202211227606 A CN202211227606 A CN 202211227606A CN 115429839 A CN115429839 A CN 115429839A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- medicine composition
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中药技术领域,且公开了一种中药组合物及其在治疗慢性乙型肝炎中的应用,由以下成分制成:羚羊骨、黄芪、当归、柴胡、丹参、大青叶、细辛、茯苓、黄芩、杜仲、厚朴、白芍、川芎、赤芍、甘草、枳实、蛇舌草;本发明制备的中药组合物,主要用于慢性乙型肝炎,能有效降低转氨酶,服用本发明制备的中药组合物,能够在开始阶段就能够阻止慢性乙型肝炎的继续发展,逐渐的修复肝脏细胞,最后,不断的恢复肝脏功能正常化。
The invention relates to the technical field of traditional Chinese medicine, and discloses a traditional Chinese medicine composition and its application in the treatment of chronic hepatitis B. Xin, Poria, Scutellaria, Eucommia, Magnolia officinalis, Radix Paeoniae Alba, Rhizoma Chuanxiong, Radix Paeoniae Rubra, Radix Glycyrrhizae, Fructus Citrifolia, Hedyotis; the traditional Chinese medicine composition prepared by the present invention is mainly used for chronic hepatitis B, and can effectively reduce transaminases. The traditional Chinese medicine composition prepared by the invention can prevent the continuous development of chronic hepatitis B at the initial stage, gradually repair liver cells, and finally, continuously restore the normalization of liver function.
Description
技术领域technical field
本发明涉及中药技术领域,具体为一种中药组合物。The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition.
背景技术Background technique
乙型肝炎是二十世纪中期对人类健康危害最大的疾病之一,病毒性乙型肝炎因其具有较强的传染性,患者遍及全球,特别是热带地区,发病率更高,对人们身体危害极大。乙型肝炎病是世界卫生组织(WHO)重点控制的传染性疾病。Hepatitis B is one of the most harmful diseases to human health in the middle of the 20th century. Viral hepatitis B is highly contagious and has patients all over the world, especially in tropical areas. The incidence is higher and it is harmful to people's health. great. Hepatitis B is an infectious disease that the World Health Organization (WHO) focuses on controlling.
慢性乙型肝炎是由乙肝病毒引起的常见疾病,主要表现为肝功能异常、呕吐、食欲减退、乏力等,部分患者可出现黄疸、发热等症状,具有一定传染性,主要通过密切接触、母婴、血液传播,男性发病率明显高于女性。慢性乙型肝炎属中医“肝瘟”“癥积”“肋痛”“黄疸”等范畴,病因为湿热毒邪,正气不足是发病的主要内在因素。血脉瘀阻的乙型肝炎患者血液瘀积在小静脉和毛细血管中,无法完全吸收出现炎症、机化,导致纤维组织增生。Chronic hepatitis B is a common disease caused by hepatitis B virus. The main manifestations are abnormal liver function, vomiting, loss of appetite, fatigue, etc. Some patients may have symptoms such as jaundice and fever. , Blood transmission, the incidence rate of men is significantly higher than that of women. Chronic hepatitis B belongs to the category of "liver plague", "syndrome", "side pain" and "jaundice" in traditional Chinese medicine. In patients with hepatitis B with blood stasis, the blood stasis in small veins and capillaries cannot be fully absorbed, leading to inflammation and organization, leading to fibrous tissue proliferation.
大量临床实践证明,中医药有助于改善慢性乙型肝炎患者临床症状、促进肝功能恢复、抑制肝纤维化进程,延缓或阻止疾病进展。A large number of clinical practices have proved that traditional Chinese medicine can help improve the clinical symptoms of patients with chronic hepatitis B, promote the recovery of liver function, inhibit the process of liver fibrosis, and delay or prevent the progression of the disease.
基于此,我们提出了一种中药组合物,希冀解决现有技术中的不足之处。Based on this, we propose a Chinese medicine composition, hoping to solve the deficiencies in the prior art.
发明内容Contents of the invention
(一)解决的技术问题(1) Solved technical problems
针对现有技术的不足,本发明提供了一种中药组合物。Aiming at the deficiencies of the prior art, the invention provides a traditional Chinese medicine composition.
(二)技术方案(2) Technical solution
为实现上述的目的,本发明提供如下技术方案:To achieve the above object, the present invention provides the following technical solutions:
一种中药组合物,按重量份计由以下成分制成:羚羊骨13-15份、黄芪10-12份、当归8-14份、柴胡12-16份、丹参2-5份、大青叶1-3份、细辛4-10份、茯苓10-20份、黄芩30-35份、杜仲11-16份、厚朴8-14份、白芍6-12份、川芎3-7份、赤芍5-10份、甘草12-18份、枳实30-35份、蛇舌草1-3份。A traditional Chinese medicine composition, which is prepared from the following ingredients in parts by weight: 13-15 parts of antelope bone, 10-12 parts of astragalus, 8-14 parts of angelica, 12-16 parts of Bupleurum, 2-5 parts of salvia miltiorrhiza, Daqing 1-3 parts of leaves, 4-10 parts of Asarum, 10-20 parts of Poria cocos, 30-35 parts of Scutellaria baicalensis, 11-16 parts of Eucommia ulmoides, 8-14 parts of Magnolia officinalis, 6-12 parts of white peony root, 3-7 parts of Chuanxiong , 5-10 parts of Radix Paeoniae Rubra, 12-18 parts of Licorice Root, 30-35 parts of Citrus Aurantium, and 1-3 parts of Hedyotis.
作为进一步的技术方案,所述黄芩与枳实混合重量份比为1:1。As a further technical solution, the mixed weight ratio of the Scutellaria baicalensis and Fructus Citrus Fructus is 1:1.
作为进一步的技术方案,所述中药组合物制备方法为:As a further technical solution, the preparation method of the Chinese medicine composition is:
(1)按各重量份称取羚羊骨、黄芪、当归、柴胡、丹参、大青叶、细辛、茯苓、黄芩、杜仲、厚朴、白芍、川芎、赤芍、甘草、枳实、蛇舌草;(1) Weigh antelope bone, astragalus root, angelica, bupleurum root, salvia miltiorrhiza, Folium chinensis, asarum, poria cocos, scutellaria baicalensis, eucommia ulmoides, Magnolia officinalis officinalis, white peony root, Chuanxiong root, red peony root, licorice root, citrus aurantium, Hedyotis;
(2)将大青叶、川芎、柴胡混合到一起,然后进行熏蒸处理20-25min,得到熏蒸料;(2) Folium Folium Folium, Rhizoma Chuanxiong and Bupleurum are mixed together, then fumigated for 20-25min to obtain the fumigation material;
(3)将羚羊骨、黄芪、当归、丹参、细辛、茯苓、杜仲、厚朴、白芍、赤芍、甘草、蛇舌草依次添加到混料机中进行混合均匀,然后取出,得到混合料;(3) Add antelope bone, astragalus, angelica, salvia miltiorrhiza, asarum, poria cocos, eucommia ulmoides, magnolia officinalis, white peony root, red peony root, licorice root, and hedyotis into the mixer in order to mix evenly, and then take it out to obtain a mixed material;
(4)向上述得到的混合料中添加其质量10-12倍的清水,浸泡处理10-15min,然后再大伙煮至沸腾,再添加上述熏蒸料,搅拌均匀后,文火煎熬2-3小时;(4) Add clear water of 10-12 times its mass to the mixture obtained above, soak it for 10-15 minutes, then boil it until it boils, then add the above-mentioned fumigating material, after stirring evenly, simmer for 2-3 hours;
(5)煎熬时间结束后,进行过滤,得到滤液;(5) After the decoction time ends, filter to obtain the filtrate;
(6)对滤液进行浓缩至原体积的50%,得到浓缩药液;(6) concentrating the filtrate to 50% of the original volume to obtain a concentrated medicinal solution;
(7)将黄芩与枳实进行粉碎,然后再用乙醇溶液对其进行回流搅拌2h,冷却至室温后继续搅拌12h,离心取上清液;(7) Grinding Scutellaria baicalensis and Fructus Aurantii Fructus Aurantii, and then using ethanol solution to reflux and stir it for 2 hours, cooling to room temperature and continuing to stir for 12 hours, centrifuging to get the supernatant;
(8)将上述得到的上清液装于透析袋中进行透析处理,透析得到的透析液进行喷雾干燥,得到混合提取物;(8) Put the supernatant obtained above into a dialysis bag for dialysis treatment, and spray-dry the dialysate obtained by dialysis to obtain a mixed extract;
(9)将硫酸钠添加到盐酸溶液中,搅拌至溶解,再添加三氯乙酸和氯化钡,继续搅拌,得到处理液;(9) Add sodium sulfate to the hydrochloric acid solution, stir until dissolved, then add trichloroacetic acid and barium chloride, and continue stirring to obtain a treatment solution;
(10)将混合提取物添加到处理液中,调节温度至50-60℃,保温搅拌反应1-2小时,得到反应液,对反应液进行调节pH至中性,然后再在透析袋中进行透析处理,透析得到的透析液进行喷雾干燥,得到药物配合剂;(10) Add the mixed extracts to the treatment solution, adjust the temperature to 50-60°C, heat and stir the reaction for 1-2 hours to obtain the reaction solution, adjust the pH of the reaction solution to neutral, and then carry out in the dialysis bag Dialysis treatment, the dialysate obtained by dialysis is spray-dried to obtain a drug compound;
(11)将药物配合剂添加到浓缩药液中,搅拌均匀,即得。(11) Add the drug compound into the concentrated drug solution, stir evenly, and the product is ready.
作为进一步的技术方案:所述步骤(2)中熏蒸处理为:采用水蒸气对大青叶、川芎、柴胡进行熏蒸处理,其中,熏蒸处理的水蒸气温度为100℃。As a further technical solution: the fumigation treatment in the step (2) is: use water vapor to fumigate Folium Folium Folium, Rhizoma Chuanxiong and Bupleurum chinensis, wherein the temperature of the water vapor in the fumigation treatment is 100°C.
作为进一步的技术方案,步骤(4)中浸泡处理为:浸泡处理为常温下进行浸泡处理。As a further technical solution, the immersion treatment in step (4) is: the immersion treatment is carried out at normal temperature.
作为进一步的技术方案,步骤(7)中所述黄芩、枳实与乙醇溶液混合的料液比为1:10-12;As a further technical scheme, the solid-liquid ratio of Scutellaria baicalensis described in step (7), Fructus Fructus Citrus Citrifolia and ethanol solution mixing is 1:10-12;
其中,所述乙醇溶液质量分数为70%。Wherein, the mass fraction of the ethanol solution is 70%.
作为进一步的技术方案:步骤(8)中所述透析袋为摩尔质量为3500DA的透析袋;As a further technical solution: the dialysis bag described in step (8) is a dialysis bag with a molar mass of 3500DA;
步骤(10)中所述透析袋为摩尔质量为3500DA的透析袋。The dialysis bag described in step (10) is a dialysis bag with a molar mass of 3500DA.
作为进一步的技术方案:步骤(9)中硫酸钠、盐酸溶液混合质量比为1-3:25;As a further technical scheme: in the step (9), the mixed mass ratio of sodium sulfate and hydrochloric acid solution is 1-3:25;
所述盐酸溶液浓度为0.1mol/L;The concentration of the hydrochloric acid solution is 0.1mol/L;
盐酸溶液、三氯乙酸和氯化钡混合质量比为25:1-3:1。The mixing mass ratio of hydrochloric acid solution, trichloroacetic acid and barium chloride is 25:1-3:1.
中药组合物应用于治疗慢性乙型肝炎。The traditional Chinese medicine composition is applied to the treatment of chronic hepatitis B.
甘草,为豆科多年生草本植物,根及根茎入药,是一种补益中草药。甘草性平、味甘,具有补脾益气、清热解毒、祛痰止咳、缓急止痛、调和诸药之功效,用于脾胃虚弱、倦怠乏力、心悸气短、咳嗽痰多、脘腹、四肢挛急疼痛、痈肿疮毒、缓解药物毒性和烈性。Licorice is a perennial herbaceous plant in the leguminous family, and its roots and rhizomes are used as medicine. It is a tonic Chinese herbal medicine. Licorice is flat in nature and sweet in taste. It has the functions of invigorating the spleen and replenishing qi, clearing heat and detoxification, eliminating phlegm and relieving cough, relieving spasm and relieving pain, and harmonizing various medicines. Pain, carbuncle sores, relieving drug toxicity and potency.
当归:甘、辛、温,归肝、心、脾经。功效:补血活血,调经止痛,润燥滑肠,主治贫血、月经不调、经闭、痛经、崩漏、产后腹痛、血虚便秘、跌打损伤、痈疽疮疡。Angelica: sweet, pungent, warm, returns liver, heart, spleen meridian. Efficacy: Tonify blood and activate blood, regulate menstruation and relieve pain, moisten dryness and smooth intestines, treat anemia, irregular menstruation, amenorrhea, dysmenorrhea, metrorrhagia, postpartum abdominal pain, blood deficiency constipation, bruises, carbuncle sores.
细辛(AsarumsieboldiiMiq),为马兜铃科、细辛属多年生草本,具有解表散寒,祛风止痛,通窍,温肺化饮功效。Asarum (AsarumsieboldiiMiq), a perennial herb of Aristolochiaceae and Asarum genus, has the functions of relieving exterior cold, expelling wind and relieving pain, clearing the orifices, warming the lungs and transforming drink.
赤芍(汉芍):苦、微寒,归肝经。功效:清热凉血,祛瘀止痛,用于温热病热在血分,能清血分郁热,本品能祛瘀行滞,活血通经。Radix Paeoniae Rubra (Han Shao): Bitter, slightly cold, returns to Liver Meridian. Efficacy: clearing heat and cooling blood, dispelling blood stasis and relieving pain, used for febrile disease and heat in the blood, can clear blood stagnation, this product can dispel blood stasis, promote blood circulation and stimulate menstruation.
茯苓,性味:甘、淡、平,具有渗湿利水、健脾和胃、宁心安神之功效,用于治疗小便不利、水肿胀满、痰饮咳逆、呕吐、脾虚食少、泄泻、心悸不安、失眠健忘、遗精白浊。Poria cocos, nature and flavor: sweet, light, flat, has the effect of diuresis and diuresis, invigorating the spleen and stomach, calming the mind and calming the nerves, used to treat dysuria, edema and fullness, cough with phlegm, vomiting, spleen deficiency, lack of food, and diarrhea , palpitations, insomnia, forgetfulness, seminal emission and white turbidity.
白芍,性味:苦、酸、微寒,养血和营、缓急止痛、敛阴平肝之功效,用于治疗月经不调、经行腹痛、崩漏、自汗、盗汗、胁肋脘腹疼痛、四肢挛痛、头痛、眩晕等症。Radix Paeoniae Alba, nature and flavor: bitter, sour, slightly cold, nourishing blood and nutrient, relieving spasm and relieving pain, astringing yin and calming the liver, used to treat irregular menstruation, abdominal pain during menstruation, metrorrhagia, spontaneous sweating, night sweats, flanks and abdomen Pain, limb spasm, headache, dizziness and other symptoms.
本发明制备的中药组合物可以通过提高免疫来治疗改善慢性乙型肝炎,同时具有抗癌变与增强体免疫力之功,具有抗癌前变异细胞的增生,能够先延缓慢性乙型肝炎进展,后改善修复肝脏细胞,改善肝脏功能,促使其恢复正常功能。The traditional Chinese medicine composition prepared by the present invention can treat and improve chronic hepatitis B by improving immunity, and at the same time has the function of anti-cancer and enhancing body immunity, has anti-proliferation of pre-cancerous mutant cells, and can first delay the progress of chronic hepatitis B, Afterwards, it improves and repairs liver cells, improves liver function, and promotes its return to normal function.
本发明提供的用于治疗慢性乙型肝炎的中药组合物,是发明人经过反复的临床实践,经过多次的对配方的优化,最后得出通过不同组合的中药水煎剂配合制备的药物配合剂的作用,二者的结合,对于治疗慢性乙型肝炎的效果具有大幅度的改善提高。The traditional Chinese medicine composition provided by the present invention for the treatment of chronic hepatitis B is the result of the inventor's repeated clinical practice and multiple optimizations of the formula, and finally obtains a drug combination prepared by combining different combinations of Chinese medicine decoctions. The combination of the two can greatly improve the effect of treating chronic hepatitis B.
本发明提供了多种用于治疗慢性乙型肝炎的中药组合物,该中药组合物的原料药包括羚羊骨、黄芪、当归、柴胡、丹参、大青叶、细辛、茯苓、杜仲、厚朴、白芍、川芎、赤芍、甘草、蛇舌草、枳实、黄芩,并且以羚羊骨、黄芪、当归、柴胡、丹参、大青叶、细辛、茯苓、杜仲、厚朴、白芍、川芎、赤芍、甘草、蛇舌草进行组合制备水煎液与枳实、黄芩制备得到的药物配合剂进行共同作用不仅可以效缓解慢性乙型肝炎患者的多种症状,同时能够修复肝脏细胞,降低慢性乙型肝炎肝炎患者肝硬化的年发生率及乙型肝炎相关性代偿期肝硬化患者原发性肝癌年发生率。The invention provides a variety of traditional Chinese medicine compositions for treating chronic hepatitis B. The raw materials of the traditional Chinese medicine composition include antelope bone, astragalus, angelica, bupleurum, salvia miltiorrhiza, Folium Folium, asarum, poria cocos, Eucommia, thick Park, white peony, Chuanxiong, red peony, licorice, hedyotis, aurantium, scutellaria baicalensis, and antelope bone, astragalus, angelica, Bupleurum, salvia miltiorrhiza, Daqingye, Asarum, Poria, Eucommia, Magnolia officinalis, white The water decoction prepared by combining peony, Chuanxiong, red peony, licorice, and Hedyotis, and the drug compound prepared by Citrus aurantium and Scutellaria baicalensis can not only effectively relieve various symptoms of patients with chronic hepatitis B, but also repair the liver. Cells, reduce the annual incidence of liver cirrhosis in patients with chronic hepatitis B hepatitis and the annual incidence of primary liver cancer in patients with hepatitis B-related compensated liver cirrhosis.
大青叶具有辅助消炎作用,药物配合剂能够有效的增强细胞免疫和体液免疫作用,能够高效的促进肝细胞的再生与修复,增强免疫力,同时还能有效的抑制肝脏细胞的受损,改善肝脏功能,促使肝脏功能恢复正常,药物配合剂不仅能抗氧化,调节免疫,抗癌,增强肝脏解毒的功能,而且还能保肝作用,药物配合剂在一定程度上修复受损肝细胞,从而降低转氨酶,保护肝脏的作用。Folium Folium has an auxiliary anti-inflammatory effect, and the drug compound can effectively enhance cellular immunity and humoral immunity, effectively promote the regeneration and repair of liver cells, enhance immunity, and at the same time effectively inhibit liver cell damage and improve Liver function, promote liver function to return to normal. The drug compound can not only resist oxidation, regulate immunity, fight cancer, enhance the function of liver detoxification, but also protect the liver. The drug compound can repair damaged liver cells to a certain extent, thereby Reduce transaminase and protect the liver.
经过长时间的用药跟踪,本发明中药组合物使慢性乙型肝炎患者肝硬化的年发生率由12.5%降至0.8%,乙型肝炎相关性代偿期肝硬化患者原发性肝癌年发生率由5.8%降至1.1%。After long-term medication tracking, the traditional Chinese medicine composition of the present invention reduces the annual incidence rate of liver cirrhosis in patients with chronic hepatitis B from 12.5% to 0.8%, and the annual incidence rate of primary liver cancer in patients with hepatitis B-related compensated liver cirrhosis From 5.8% to 1.1%.
黄芪对肝脏有保护作用,可增强小肠运动各平滑肌紧张度,黄芪有抗菌,抗病毒的作用,它还有造血和免疫系统有保护作用。Astragalus has a protective effect on the liver and can enhance the smooth muscle tension of the small intestine. Astragalus has antibacterial and antiviral effects. It also has protective effects on hematopoietic and immune systems.
(三)有益效果(3) Beneficial effects
与现有技术相比,本发明提供了一种中药组合物,具备以下有益效果:Compared with the prior art, the present invention provides a traditional Chinese medicine composition, which has the following beneficial effects:
本发明制备的中药组合物,主要用于慢性乙型肝炎,能有效降低转氨酶,服用本发明制备的中药组合物,能够在开始阶段就能够阻止慢性乙型肝炎的继续发展,逐渐的修复肝脏细胞,最后,不断的恢复肝脏功能正常化。The traditional Chinese medicine composition prepared by the present invention is mainly used for chronic hepatitis B, and can effectively reduce transaminase. Taking the traditional Chinese medicine composition prepared by the present invention can prevent the continuous development of chronic hepatitis B at the initial stage, and gradually repair liver cells , and finally, the constant restoration of liver function normalization.
附图说明Description of drawings
图1为实施例与对比例临床症状和体征情况改善率柱状图;Fig. 1 is the histogram of embodiment and comparative example clinical symptom and sign situation improvement rate;
图2为实施例与对比例治疗前后肝功能ALT的柱状图。Fig. 2 is a histogram of liver function ALT before and after treatment in the embodiment and the comparative example.
具体实施方式detailed description
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Apparently, the described embodiments are only some of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.
以下为具体实施例:The following are specific examples:
实施例1Example 1
一种中药组合物,按重量份计由以下成分制成:羚羊骨13份、黄芪10份、当归8份、柴胡12份、丹参2份、大青叶1份、细辛4份、茯苓10份、黄芩30份、杜仲11份、厚朴8份、白芍6份、川芎3份、赤芍5份、甘草12份、枳实30份、蛇舌草1份,所述黄芩与枳实混合重量份比为1:1。A traditional Chinese medicine composition, prepared from the following ingredients in parts by weight: 13 parts of antelope bone, 10 parts of astragalus, 8 parts of angelica, 12 parts of Bupleurum, 2 parts of salvia miltiorrhiza, 1 part of Daqingye, 4 parts of Asarum, Poria cocos 10 parts, 30 parts of Scutellaria baicalensis, 11 parts of Eucommia ulmoides, 8 parts of Magnolia officinalis, 6 parts of white peony, 3 parts of Chuanxiong, 5 parts of red peony, 12 parts of licorice, 30 parts of Citrus aurantium, 1 part of Hedyotis The actual mixing weight ratio is 1:1.
所述中药组合物制备方法为:The preparation method of the Chinese medicine composition is:
(1)按各重量份称取羚羊骨、黄芪、当归、柴胡、丹参、大青叶、细辛、茯苓、黄芩、杜仲、厚朴、白芍、川芎、赤芍、甘草、枳实、蛇舌草;(1) Weigh antelope bone, astragalus root, angelica, bupleurum root, salvia miltiorrhiza, Folium chinensis, asarum, poria cocos, scutellaria baicalensis, eucommia ulmoides, Magnolia officinalis officinalis, white peony root, Chuanxiong root, red peony root, licorice root, citrus aurantium, Hedyotis;
(2)将大青叶、川芎、柴胡混合到一起,然后进行熏蒸处理20min,得到熏蒸料,采用水蒸气对大青叶、川芎、柴胡进行熏蒸处理,其中,熏蒸处理的水蒸气温度为100℃;(2) Folium Folium Folium, Rhizoma Chuanxiong, and Bupleurum are mixed together, and then fumigation is carried out for 20 minutes to obtain a fumigation material, and water vapor is used to fumigate Folium Folium, Rhizoma Chuanxiong, and Bupleurum, wherein the water vapor temperature of the fumigation is at 100°C;
(3)将羚羊骨、黄芪、当归、丹参、细辛、茯苓、杜仲、厚朴、白芍、赤芍、甘草、蛇舌草依次添加到混料机中进行混合均匀,然后取出,得到混合料;(3) Add antelope bone, astragalus, angelica, salvia miltiorrhiza, asarum, poria cocos, eucommia ulmoides, magnolia officinalis, white peony root, red peony root, licorice root, and hedyotis into the mixer in order to mix evenly, and then take it out to obtain a mixed material;
(4)向上述得到的混合料中添加其质量10倍的清水,浸泡处理10min,然后再大伙煮至沸腾,再添加上述熏蒸料,搅拌均匀后,文火煎熬2小时,浸泡处理为常温下进行浸泡处理;(4) Add clear water 10 times its mass to the mixture obtained above, soak it for 10 minutes, then boil it until it boils, then add the above-mentioned fumigation material, stir evenly, simmer for 2 hours, and soak it at room temperature Soaking treatment;
(5)煎熬时间结束后,进行过滤,得到滤液;(5) After the decoction time ends, filter to obtain the filtrate;
(6)对滤液进行浓缩至原体积的50%,得到浓缩药液;(6) concentrating the filtrate to 50% of the original volume to obtain a concentrated medicinal solution;
(7)将黄芩与枳实进行粉碎,然后再用乙醇溶液对其进行回流搅拌2h,冷却至室温后继续搅拌12h,离心取上清液,黄芩、枳实与乙醇溶液混合的料液比为1:10;(7) Pulverize Scutellaria baicalensis and Fructus Aurantii Fructus, then reflux and stir it with ethanol solution for 2h, continue to stir for 12h after cooling to room temperature, centrifuge to get the supernatant, the solid-liquid ratio of Scutellaria baicalensis, Fructus Fructus Fructus Fructus Citrifolia and ethanol solution is mixed as 1:10;
其中,所述乙醇溶液质量分数为70%;Wherein, the ethanol solution mass fraction is 70%;
(8)将上述得到的上清液装于摩尔质量为3500DA的透析袋中进行透析处理,透析得到的透析液进行喷雾干燥,得到混合提取物;(8) The supernatant obtained above is placed in a dialysis bag with a molar mass of 3500DA for dialysis treatment, and the dialysate obtained by the dialysis is spray-dried to obtain a mixed extract;
(9)将硫酸钠添加到盐酸溶液中,搅拌至溶解,再添加三氯乙酸和氯化钡,继续搅拌,得到处理液,硫酸钠、盐酸溶液混合质量比为1:25;(9) Add sodium sulfate to the hydrochloric acid solution, stir until dissolved, then add trichloroacetic acid and barium chloride, continue stirring to obtain a treatment solution, the mixing mass ratio of sodium sulfate and hydrochloric acid solution is 1:25;
所述盐酸溶液浓度为0.1mol/L;The concentration of the hydrochloric acid solution is 0.1mol/L;
盐酸溶液、三氯乙酸和氯化钡混合质量比为25:1:1;The mixing mass ratio of hydrochloric acid solution, trichloroacetic acid and barium chloride is 25:1:1;
(10)将混合提取物添加到处理液中,调节温度至50℃,保温搅拌反应1小时,得到反应液,对反应液进行调节pH至中性,然后再在摩尔质量为3500DA的透析袋中进行透析处理,透析得到的透析液进行喷雾干燥,得到药物配合剂;(10) Add the mixed extracts to the treatment solution, adjust the temperature to 50°C, heat and stir the reaction for 1 hour to obtain a reaction solution, adjust the pH of the reaction solution to neutral, and then place it in a dialysis bag with a molar mass of 3500DA Carry out dialysis treatment, and the dialysate obtained by dialysis is spray-dried to obtain a drug compound;
(11)将药物配合剂添加到浓缩药液中,搅拌均匀,即得。(11) Add the drug compound into the concentrated drug solution, stir evenly, and the product is ready.
实施例2Example 2
一种中药组合物,按重量份计由以下成分制成:羚羊骨14份、黄芪11份、当归10份、柴胡13份、丹参4份、大青叶2份、细辛5份、茯苓12份、黄芩31份、杜仲12份、厚朴10份、白芍8份、川芎4份、赤芍6份、甘草14份、枳实31份、蛇舌草2份,所述黄芩与枳实混合重量份比为1:1。A traditional Chinese medicine composition, which is prepared from the following ingredients in parts by weight: 14 parts of antelope bone, 11 parts of astragalus, 10 parts of angelica, 13 parts of Bupleurum, 4 parts of Salvia miltiorrhiza, 2 parts of Daqingye, 5 parts of Asarum, Poria cocos 12 parts, 31 parts of Scutellaria baicalensis, 12 parts of Eucommia ulmoides, 10 parts of Magnolia officinalis, 8 parts of white peony, 4 parts of Chuanxiong, 6 parts of red peony, 14 parts of licorice, 31 parts of Citrus aurantii, 2 parts of Hedyotis. The actual mixing weight ratio is 1:1.
所述中药组合物制备方法为:The preparation method of the Chinese medicine composition is:
(1)按各重量份称取羚羊骨、黄芪、当归、柴胡、丹参、大青叶、细辛、茯苓、黄芩、杜仲、厚朴、白芍、川芎、赤芍、甘草、枳实、蛇舌草;(1) Weigh antelope bone, astragalus root, angelica, bupleurum root, salvia miltiorrhiza, Folium chinensis, asarum, poria cocos, scutellaria baicalensis, eucommia ulmoides, Magnolia officinalis officinalis, white peony root, Chuanxiong root, red peony root, licorice root, citrus aurantium, Hedyotis;
(2)将大青叶、川芎、柴胡混合到一起,然后进行熏蒸处理22min,得到熏蒸料,采用水蒸气对大青叶、川芎、柴胡进行熏蒸处理,其中,熏蒸处理的水蒸气温度为100℃;(2) Folium Folium Folium, Rhizoma Chuanxiong, and Bupleurum are mixed together, and then fumigated for 22 minutes to obtain a fumigation material, and water vapor is used to fumigate Folium Folium, Rhizoma Chuanxiong, and Bupleurum, wherein the water vapor temperature of the fumigation is at 100°C;
(3)将羚羊骨、黄芪、当归、丹参、细辛、茯苓、杜仲、厚朴、白芍、赤芍、甘草、蛇舌草依次添加到混料机中进行混合均匀,然后取出,得到混合料;(3) Add antelope bone, astragalus, angelica, salvia miltiorrhiza, asarum, poria cocos, eucommia ulmoides, magnolia officinalis, white peony root, red peony root, licorice root, and hedyotis into the mixer in order to mix evenly, and then take it out to obtain a mixed material;
(4)向上述得到的混合料中添加其质量11倍的清水,浸泡处理12min,然后再大伙煮至沸腾,再添加上述熏蒸料,搅拌均匀后,文火煎熬2.5小时,浸泡处理为常温下进行浸泡处理;(4) Add clear water of 11 times its mass to the mixture obtained above, soak it for 12 minutes, then boil it until it boils, then add the above-mentioned fumigation material, stir evenly, simmer for 2.5 hours, and soak it at room temperature Soaking treatment;
(5)煎熬时间结束后,进行过滤,得到滤液;(5) After the decoction time ends, filter to obtain the filtrate;
(6)对滤液进行浓缩至原体积的50%,得到浓缩药液;(6) concentrating the filtrate to 50% of the original volume to obtain a concentrated medicinal solution;
(7)将黄芩与枳实进行粉碎,然后再用乙醇溶液对其进行回流搅拌2h,冷却至室温后继续搅拌12h,离心取上清液,黄芩、枳实与乙醇溶液混合的料液比为1:11;(7) Pulverize Scutellaria baicalensis and Fructus Aurantii Fructus, then reflux and stir it with ethanol solution for 2h, continue to stir for 12h after cooling to room temperature, centrifuge to get the supernatant, the solid-liquid ratio of Scutellaria baicalensis, Fructus Fructus Fructus Fructus Citrifolia and ethanol solution is mixed as 1:11;
其中,所述乙醇溶液质量分数为70%;Wherein, the ethanol solution mass fraction is 70%;
(8)将上述得到的上清液装于摩尔质量为3500DA的透析袋中进行透析处理,透析得到的透析液进行喷雾干燥,得到混合提取物;(8) The supernatant obtained above is placed in a dialysis bag with a molar mass of 3500DA for dialysis treatment, and the dialysate obtained by the dialysis is spray-dried to obtain a mixed extract;
(9)将硫酸钠添加到盐酸溶液中,搅拌至溶解,再添加三氯乙酸和氯化钡,继续搅拌,得到处理液,硫酸钠、盐酸溶液混合质量比为2:25;(9) Add sodium sulfate to the hydrochloric acid solution, stir until dissolved, then add trichloroacetic acid and barium chloride, continue stirring to obtain a treatment solution, the mixing mass ratio of sodium sulfate and hydrochloric acid solution is 2:25;
所述盐酸溶液浓度为0.1mol/L;The concentration of the hydrochloric acid solution is 0.1mol/L;
盐酸溶液、三氯乙酸和氯化钡混合质量比为25:2:1;The mixed mass ratio of hydrochloric acid solution, trichloroacetic acid and barium chloride is 25:2:1;
(10)将混合提取物添加到处理液中,调节温度至55℃,保温搅拌反应1.5小时,得到反应液,对反应液进行调节pH至中性,然后再在摩尔质量为3500DA的透析袋中进行透析处理,透析得到的透析液进行喷雾干燥,得到药物配合剂;(10) Add the mixed extracts to the treatment solution, adjust the temperature to 55°C, heat and stir for 1.5 hours to obtain a reaction solution, adjust the pH of the reaction solution to neutral, and then place it in a dialysis bag with a molar mass of 3500DA Carry out dialysis treatment, and the dialysate obtained by dialysis is spray-dried to obtain a drug compound;
(11)将药物配合剂添加到浓缩药液中,搅拌均匀,即得。(11) Add the drug compound into the concentrated drug solution, stir evenly, and the product is ready.
实施例3Example 3
一种中药组合物,按重量份计由以下成分制成:羚羊骨14份、黄芪11份、当归10份、柴胡14份、丹参3份、大青叶2份、细辛5份、茯苓15份、黄芩32份、杜仲14份、厚朴12份、白芍8份、川芎4份、赤芍6份、甘草15份、枳实32份、蛇舌草2份所述黄芩与枳实混合重量份比为1:1。A traditional Chinese medicine composition, which is prepared from the following ingredients in parts by weight: 14 parts of antelope bone, 11 parts of astragalus, 10 parts of angelica, 14 parts of Bupleurum, 3 parts of Salvia miltiorrhiza, 2 parts of Daqingye, 5 parts of Asarum, Poria cocos 15 parts, 32 parts of Scutellaria baicalensis, 14 parts of Eucommia ulmoides, 12 parts of Magnolia officinalis, 8 parts of white peony, 4 parts of Chuanxiong, 6 parts of red peony, 15 parts of licorice, 32 parts of Citrus aurantium, 2 parts of Hedyotis. The mixing weight ratio is 1:1.
所述中药组合物制备方法为:The preparation method of the Chinese medicine composition is:
(1)按各重量份称取羚羊骨、黄芪、当归、柴胡、丹参、大青叶、细辛、茯苓、黄芩、杜仲、厚朴、白芍、川芎、赤芍、甘草、枳实、蛇舌草;(1) Weigh antelope bone, astragalus root, angelica, bupleurum root, salvia miltiorrhiza, Folium chinensis, asarum, poria cocos, scutellaria baicalensis, eucommia ulmoides, Magnolia officinalis officinalis, white peony root, Chuanxiong root, red peony root, licorice root, citrus aurantium, Hedyotis;
(2)将大青叶、川芎、柴胡混合到一起,然后进行熏蒸处理22min,得到熏蒸料,采用水蒸气对大青叶、川芎、柴胡进行熏蒸处理,其中,熏蒸处理的水蒸气温度为100℃;(2) Folium Folium Folium, Rhizoma Chuanxiong, and Bupleurum are mixed together, and then fumigated for 22 minutes to obtain a fumigation material, and water vapor is used to fumigate Folium Folium, Rhizoma Chuanxiong, and Bupleurum, wherein the water vapor temperature of the fumigation is at 100°C;
(3)将羚羊骨、黄芪、当归、丹参、细辛、茯苓、杜仲、厚朴、白芍、赤芍、甘草、蛇舌草依次添加到混料机中进行混合均匀,然后取出,得到混合料;(3) Add antelope bone, astragalus, angelica, salvia miltiorrhiza, asarum, poria cocos, eucommia ulmoides, magnolia officinalis, white peony root, red peony root, licorice root, and hedyotis into the mixer in order to mix evenly, and then take it out to obtain a mixed material;
(4)向上述得到的混合料中添加其质量11倍的清水,浸泡处理12min,然后再大伙煮至沸腾,再添加上述熏蒸料,搅拌均匀后,文火煎熬2.5小时,浸泡处理为常温下进行浸泡处理;(4) Add clear water of 11 times its mass to the mixture obtained above, soak it for 12 minutes, then boil it until it boils, then add the above-mentioned fumigation material, stir evenly, simmer for 2.5 hours, and soak it at room temperature Soaking treatment;
(5)煎熬时间结束后,进行过滤,得到滤液;(5) After the decoction time ends, filter to obtain the filtrate;
(6)对滤液进行浓缩至原体积的50%,得到浓缩药液;(6) concentrating the filtrate to 50% of the original volume to obtain a concentrated medicinal solution;
(7)将黄芩与枳实进行粉碎,然后再用乙醇溶液对其进行回流搅拌2h,冷却至室温后继续搅拌12h,离心取上清液,黄芩、枳实与乙醇溶液混合的料液比为1:11;(7) Pulverize Scutellaria baicalensis and Fructus Aurantii Fructus, then reflux and stir it with ethanol solution for 2h, continue to stir for 12h after cooling to room temperature, centrifuge to get the supernatant, the solid-liquid ratio of Scutellaria baicalensis, Fructus Fructus Fructus Fructus Citrifolia and ethanol solution is mixed as 1:11;
其中,所述乙醇溶液质量分数为70%;Wherein, the ethanol solution mass fraction is 70%;
(8)将上述得到的上清液装于摩尔质量为3500DA的透析袋中进行透析处理,透析得到的透析液进行喷雾干燥,得到混合提取物;(8) The supernatant obtained above is placed in a dialysis bag with a molar mass of 3500DA for dialysis treatment, and the dialysate obtained by the dialysis is spray-dried to obtain a mixed extract;
(9)将硫酸钠添加到盐酸溶液中,搅拌至溶解,再添加三氯乙酸和氯化钡,继续搅拌,得到处理液,硫酸钠、盐酸溶液混合质量比为2:25;(9) Add sodium sulfate to the hydrochloric acid solution, stir until dissolved, then add trichloroacetic acid and barium chloride, continue stirring to obtain a treatment solution, the mixing mass ratio of sodium sulfate and hydrochloric acid solution is 2:25;
所述盐酸溶液浓度为0.1mol/L;The concentration of the hydrochloric acid solution is 0.1mol/L;
盐酸溶液、三氯乙酸和氯化钡混合质量比为25:2:1;The mixed mass ratio of hydrochloric acid solution, trichloroacetic acid and barium chloride is 25:2:1;
(10)将混合提取物添加到处理液中,调节温度至55℃,保温搅拌反应1.5小时,得到反应液,对反应液进行调节pH至中性,然后再在摩尔质量为3500DA的透析袋中进行透析处理,透析得到的透析液进行喷雾干燥,得到药物配合剂;(10) Add the mixed extracts to the treatment solution, adjust the temperature to 55°C, heat and stir for 1.5 hours to obtain a reaction solution, adjust the pH of the reaction solution to neutral, and then place it in a dialysis bag with a molar mass of 3500DA Carry out dialysis treatment, and the dialysate obtained by dialysis is spray-dried to obtain a drug compound;
(11)将药物配合剂添加到浓缩药液中,搅拌均匀,即得。(11) Add the drug compound into the concentrated drug solution, stir evenly, and the product is ready.
实施例4Example 4
一种中药组合物,按重量份计由以下成分制成:羚羊骨14份、黄芪11份、当归12份、柴胡15份、丹参4份、大青叶2份、细辛5份、茯苓18份、黄芩34份、杜仲15份、厚朴12份、白芍10份、川芎5份、赤芍8份、甘草15份、枳实34份、蛇舌草2份,所述黄芩与枳实混合重量份比为1:1。A traditional Chinese medicine composition, prepared from the following ingredients in parts by weight: 14 parts of antelope bone, 11 parts of astragalus, 12 parts of angelica, 15 parts of Bupleurum, 4 parts of salvia miltiorrhiza, 2 parts of Daqingye, 5 parts of Asarum, Poria cocos 18 parts, 34 parts of Scutellaria baicalensis, 15 parts of Eucommia ulmoides, 12 parts of Magnolia officinalis, 10 parts of white peony, 5 parts of Chuanxiong, 8 parts of red peony, 15 parts of licorice, 34 parts of Citrus aurantium, 2 parts of Hedyotis The actual mixing weight ratio is 1:1.
所述中药组合物制备方法为:The preparation method of the Chinese medicine composition is:
(1)按各重量份称取羚羊骨、黄芪、当归、柴胡、丹参、大青叶、细辛、茯苓、黄芩、杜仲、厚朴、白芍、川芎、赤芍、甘草、枳实、蛇舌草;(1) Weigh antelope bone, astragalus root, angelica, bupleurum root, salvia miltiorrhiza, Folium chinensis, asarum, poria cocos, scutellaria baicalensis, eucommia ulmoides, Magnolia officinalis officinalis, white peony root, Chuanxiong root, red peony root, licorice root, citrus aurantium, Hedyotis;
(2)将大青叶、川芎、柴胡混合到一起,然后进行熏蒸处理24min,得到熏蒸料,采用水蒸气对大青叶、川芎、柴胡进行熏蒸处理,其中,熏蒸处理的水蒸气温度为100℃;(2) Folium Folium Folium, Rhizoma Chuanxiong, and Bupleurum are mixed together, and then fumigated for 24 minutes to obtain a fumigation material, and water vapor is used to fumigate Folium Folium, Rhizoma Chuanxiong, and Bupleurum, wherein the water vapor temperature of the fumigation is at 100°C;
(3)将羚羊骨、黄芪、当归、丹参、细辛、茯苓、杜仲、厚朴、白芍、赤芍、甘草、蛇舌草依次添加到混料机中进行混合均匀,然后取出,得到混合料;(3) Add antelope bone, astragalus, angelica, salvia miltiorrhiza, asarum, poria cocos, eucommia ulmoides, magnolia officinalis, white peony root, red peony root, licorice root, and hedyotis into the mixer in order to mix evenly, and then take it out to obtain a mixed material;
(4)向上述得到的混合料中添加其质量11倍的清水,浸泡处理12min,然后再大伙煮至沸腾,再添加上述熏蒸料,搅拌均匀后,文火煎熬2.5小时,浸泡处理为常温下进行浸泡处理;(4) Add clear water of 11 times its mass to the mixture obtained above, soak it for 12 minutes, then boil it until it boils, then add the above-mentioned fumigation material, stir evenly, simmer for 2.5 hours, and soak it at room temperature Soaking treatment;
(5)煎熬时间结束后,进行过滤,得到滤液;(5) After the decoction time ends, filter to obtain the filtrate;
(6)对滤液进行浓缩至原体积的50%,得到浓缩药液;(6) concentrating the filtrate to 50% of the original volume to obtain a concentrated medicinal solution;
(7)将黄芩与枳实进行粉碎,然后再用乙醇溶液对其进行回流搅拌2h,冷却至室温后继续搅拌12h,离心取上清液,黄芩、枳实与乙醇溶液混合的料液比为1:11;(7) Pulverize Scutellaria baicalensis and Fructus Aurantii Fructus, then reflux and stir it with ethanol solution for 2h, continue to stir for 12h after cooling to room temperature, centrifuge to get the supernatant, the solid-liquid ratio of Scutellaria baicalensis, Fructus Fructus Fructus Fructus Citrifolia and ethanol solution is mixed as 1:11;
其中,所述乙醇溶液质量分数为70%;Wherein, the ethanol solution mass fraction is 70%;
(8)将上述得到的上清液装于摩尔质量为3500DA的透析袋中进行透析处理,透析得到的透析液进行喷雾干燥,得到混合提取物;(8) The supernatant obtained above is placed in a dialysis bag with a molar mass of 3500DA for dialysis treatment, and the dialysate obtained by the dialysis is spray-dried to obtain a mixed extract;
(9)将硫酸钠添加到盐酸溶液中,搅拌至溶解,再添加三氯乙酸和氯化钡,继续搅拌,得到处理液,硫酸钠、盐酸溶液混合质量比为2:25;(9) Add sodium sulfate to the hydrochloric acid solution, stir until dissolved, then add trichloroacetic acid and barium chloride, continue stirring to obtain a treatment solution, the mixing mass ratio of sodium sulfate and hydrochloric acid solution is 2:25;
所述盐酸溶液浓度为0.1mol/L;The concentration of the hydrochloric acid solution is 0.1mol/L;
盐酸溶液、三氯乙酸和氯化钡混合质量比为25:2:1;The mixed mass ratio of hydrochloric acid solution, trichloroacetic acid and barium chloride is 25:2:1;
(10)将混合提取物添加到处理液中,调节温度至50-60℃,保温搅拌反应1-2小时,得到反应液,对反应液进行调节pH至中性,然后再在摩尔质量为3500DA的透析袋中进行透析处理,透析得到的透析液进行喷雾干燥,得到药物配合剂;(10) Add the mixed extract to the treatment solution, adjust the temperature to 50-60°C, heat and stir the reaction for 1-2 hours to obtain the reaction solution, adjust the pH of the reaction solution to neutral, and then adjust the pH of the reaction solution to 3500DA Carry out dialysis treatment in the dialysis bag of dialysis, the dialysate obtained by dialysis is spray-dried to obtain the drug compound;
(11)将药物配合剂添加到浓缩药液中,搅拌均匀,即得。(11) Add the drug compound into the concentrated drug solution, stir evenly, and the product is ready.
实施例5Example 5
一种中药组合物,按重量份计由以下成分制成:羚羊骨15份、黄芪12份、当归14份、柴胡16份、丹参5份、大青叶3份、细辛10份、茯苓20份、黄芩35份、杜仲16份、厚朴14份、白芍12份、川芎7份、赤芍10份、甘草18份、枳实35份、蛇舌草3份,所述黄芩与枳实混合重量份比为1:1。A traditional Chinese medicine composition, prepared from the following ingredients in parts by weight: 15 parts of antelope bone, 12 parts of astragalus, 14 parts of angelica, 16 parts of Bupleurum, 5 parts of salvia miltiorrhiza, 3 parts of Daqingye, 10 parts of Asarum, Poria cocos 20 parts, 35 parts of Scutellaria baicalensis, 16 parts of Eucommia ulmoides, 14 parts of Magnolia officinalis, 12 parts of white peony, 7 parts of Chuanxiong, 10 parts of red peony, 18 parts of licorice, 35 parts of Citrus aurantium, 3 parts of Hedyotis, The actual mixing weight ratio is 1:1.
所述中药组合物制备方法为:The preparation method of the Chinese medicine composition is:
(1)按各重量份称取羚羊骨、黄芪、当归、柴胡、丹参、大青叶、细辛、茯苓、黄芩、杜仲、厚朴、白芍、川芎、赤芍、甘草、枳实、蛇舌草;(1) Weigh antelope bone, astragalus root, angelica, bupleurum root, salvia miltiorrhiza, Folium chinensis, asarum, poria cocos, scutellaria baicalensis, eucommia ulmoides, Magnolia officinalis officinalis, white peony root, Chuanxiong root, red peony root, licorice root, citrus aurantium, Hedyotis;
(2)将大青叶、川芎、柴胡混合到一起,然后进行熏蒸处理25min,得到熏蒸料,采用水蒸气对大青叶、川芎、柴胡进行熏蒸处理,其中,熏蒸处理的水蒸气温度为100℃;(2) Folium Folium Folium, Rhizoma Chuanxiong, and Bupleurum are mixed together, and then fumigation is carried out for 25 minutes to obtain a fumigation material, and water vapor is used to fumigate Folium Folium, Rhizoma Chuanxiong, and Bupleurum, wherein the water vapor temperature of the fumigation is at 100°C;
(3)将羚羊骨、黄芪、当归、丹参、细辛、茯苓、杜仲、厚朴、白芍、赤芍、甘草、蛇舌草依次添加到混料机中进行混合均匀,然后取出,得到混合料;(3) Add antelope bone, astragalus, angelica, salvia miltiorrhiza, asarum, poria cocos, eucommia ulmoides, magnolia officinalis, white peony root, red peony root, licorice root, and hedyotis into the mixer in order to mix evenly, and then take it out to obtain a mixed material;
(4)向上述得到的混合料中添加其质量12倍的清水,浸泡处理15min,然后再大伙煮至沸腾,再添加上述熏蒸料,搅拌均匀后,文火煎熬3小时,浸泡处理为常温下进行浸泡处理;(4) Add clear water of 12 times its mass to the mixture obtained above, soak it for 15 minutes, then boil it until it boils, then add the above-mentioned fumigating material, after stirring evenly, simmer for 3 hours, and the soaking treatment is carried out at room temperature Soaking treatment;
(5)煎熬时间结束后,进行过滤,得到滤液;(5) After the decoction time ends, filter to obtain the filtrate;
(6)对滤液进行浓缩至原体积的50%,得到浓缩药液;(6) concentrating the filtrate to 50% of the original volume to obtain a concentrated medicinal solution;
(7)将黄芩与枳实进行粉碎,然后再用乙醇溶液对其进行回流搅拌2h,冷却至室温后继续搅拌12h,离心取上清液,黄芩、枳实与乙醇溶液混合的料液比为1:12;(7) Pulverize Scutellaria baicalensis and Fructus Aurantii Fructus, then reflux and stir it with ethanol solution for 2h, continue to stir for 12h after cooling to room temperature, centrifuge to get the supernatant, the solid-liquid ratio of Scutellaria baicalensis, Fructus Fructus Fructus Fructus Citrifolia and ethanol solution is mixed as 1:12;
其中,所述乙醇溶液质量分数为70%;Wherein, the ethanol solution mass fraction is 70%;
(8)将上述得到的上清液装于摩尔质量为3500DA的透析袋中进行透析处理,透析得到的透析液进行喷雾干燥,得到混合提取物;(8) The supernatant obtained above is placed in a dialysis bag with a molar mass of 3500DA for dialysis treatment, and the dialysate obtained by the dialysis is spray-dried to obtain a mixed extract;
(9)将硫酸钠添加到盐酸溶液中,搅拌至溶解,再添加三氯乙酸和氯化钡,继续搅拌,得到处理液,硫酸钠、盐酸溶液混合质量比为3:25;(9) Add sodium sulfate to the hydrochloric acid solution, stir until dissolved, then add trichloroacetic acid and barium chloride, continue stirring to obtain a treatment solution, the mixing mass ratio of sodium sulfate and hydrochloric acid solution is 3:25;
所述盐酸溶液浓度为0.1mol/L;The concentration of the hydrochloric acid solution is 0.1mol/L;
盐酸溶液、三氯乙酸和氯化钡混合质量比为25:3:1;The mixing mass ratio of hydrochloric acid solution, trichloroacetic acid and barium chloride is 25:3:1;
(10)将混合提取物添加到处理液中,调节温度至60℃,保温搅拌反应2小时,得到反应液,对反应液进行调节pH至中性,然后再在摩尔质量为3500DA的透析袋中进行透析处理,透析得到的透析液进行喷雾干燥,得到药物配合剂;(10) Add the mixed extracts to the treatment solution, adjust the temperature to 60°C, heat and stir the reaction for 2 hours to obtain a reaction solution, adjust the pH of the reaction solution to neutral, and then place it in a dialysis bag with a molar mass of 3500DA Carry out dialysis treatment, and the dialysate obtained by dialysis is spray-dried to obtain a drug compound;
(11)将药物配合剂添加到浓缩药液中,搅拌均匀,即得。(11) Add the drug compound into the concentrated drug solution, stir evenly, and the product is ready.
对比例1:Comparative example 1:
一种中药组合物,按重量份计由以下成分制成:羚羊骨13份、黄芪10份、当归8份、柴胡12份、丹参2份、大青叶1份、细辛4份、茯苓10份、杜仲11份、厚朴8份、白芍6份、川芎3份、赤芍5份、甘草12份、蛇舌草1份。A traditional Chinese medicine composition, prepared from the following ingredients in parts by weight: 13 parts of antelope bone, 10 parts of astragalus, 8 parts of angelica, 12 parts of Bupleurum, 2 parts of salvia miltiorrhiza, 1 part of Daqingye, 4 parts of Asarum, Poria cocos 10 parts, 11 parts of Eucommia, 8 parts of Magnolia officinalis, 6 parts of white peony, 3 parts of Chuanxiong, 5 parts of red peony, 12 parts of licorice, and 1 part of Hedyotis.
所述中药组合物制备方法为:The preparation method of the Chinese medicine composition is:
(1)按各重量份称取羚羊骨、黄芪、当归、柴胡、丹参、大青叶、细辛、茯苓、黄芩、杜仲、厚朴、白芍、川芎、赤芍、甘草、枳实、蛇舌草;(1) Weigh antelope bone, astragalus root, angelica, bupleurum root, salvia miltiorrhiza, Folium chinensis, asarum, poria cocos, scutellaria baicalensis, eucommia ulmoides, Magnolia officinalis officinalis, white peony root, Chuanxiong root, red peony root, licorice root, citrus aurantium, Hedyotis;
(2)将大青叶、川芎、柴胡混合到一起,然后进行熏蒸处理20min,得到熏蒸料,采用水蒸气对大青叶、川芎、柴胡进行熏蒸处理,其中,熏蒸处理的水蒸气温度为100℃;(2) Folium Folium Folium, Rhizoma Chuanxiong, and Bupleurum are mixed together, and then fumigation is carried out for 20 minutes to obtain a fumigation material, and water vapor is used to fumigate Folium Folium, Rhizoma Chuanxiong, and Bupleurum, wherein the water vapor temperature of the fumigation is at 100°C;
(3)将羚羊骨、黄芪、当归、丹参、细辛、茯苓、杜仲、厚朴、白芍、赤芍、甘草、蛇舌草依次添加到混料机中进行混合均匀,然后取出,得到混合料;(3) Add antelope bone, astragalus, angelica, salvia miltiorrhiza, asarum, poria cocos, eucommia ulmoides, magnolia officinalis, white peony root, red peony root, licorice root, and hedyotis into the mixer in order to mix evenly, and then take it out to obtain a mixed material;
(4)向上述得到的混合料中添加其质量10倍的清水,浸泡处理10min,然后再大伙煮至沸腾,再添加上述熏蒸料,搅拌均匀后,文火煎熬2小时,浸泡处理为常温下进行浸泡处理;(4) Add clear water 10 times its mass to the mixture obtained above, soak it for 10 minutes, then boil it until it boils, then add the above-mentioned fumigation material, stir evenly, simmer for 2 hours, and soak it at room temperature Soaking treatment;
(5)煎熬时间结束后,进行过滤,得到滤液;(5) After the decoction time ends, filter to obtain the filtrate;
(6)对滤液进行浓缩至原体积的50%,得到浓缩药液。(6) Concentrating the filtrate to 50% of the original volume to obtain a concentrated medicinal solution.
对比例2:Comparative example 2:
一种中药组合物,按重量份计由以下成分制成:羚羊骨13份、黄芪10份、当归8份、柴胡12份、丹参2份、大青叶1份、细辛4份、茯苓10份、黄芩30份、杜仲11份、厚朴8份、白芍6份、川芎3份、赤芍5份、甘草12份、蛇舌草1份。A traditional Chinese medicine composition, prepared from the following ingredients in parts by weight: 13 parts of antelope bone, 10 parts of astragalus, 8 parts of angelica, 12 parts of Bupleurum, 2 parts of salvia miltiorrhiza, 1 part of Daqingye, 4 parts of Asarum, Poria cocos 10 parts, 30 parts of Scutellaria baicalensis, 11 parts of Eucommia ulmoides, 8 parts of Magnolia officinalis, 6 parts of white peony, 3 parts of Chuanxiong, 5 parts of red peony, 12 parts of licorice, and 1 part of Hedyotis.
所述中药组合物制备方法为:The preparation method of the Chinese medicine composition is:
(1)按各重量份称取羚羊骨、黄芪、当归、柴胡、丹参、大青叶、细辛、茯苓、黄芩、杜仲、厚朴、白芍、川芎、赤芍、甘草、枳实、蛇舌草;(1) Weigh antelope bone, astragalus root, angelica, bupleurum root, salvia miltiorrhiza, Folium chinensis, asarum, poria cocos, scutellaria baicalensis, eucommia ulmoides, Magnolia officinalis officinalis, white peony root, Chuanxiong root, red peony root, licorice root, citrus aurantium, Hedyotis;
(2)将大青叶、川芎、柴胡混合到一起,然后进行熏蒸处理20min,得到熏蒸料,采用水蒸气对大青叶、川芎、柴胡进行熏蒸处理,其中,熏蒸处理的水蒸气温度为100℃;(2) Folium Folium Folium, Rhizoma Chuanxiong, and Bupleurum are mixed together, and then fumigation is carried out for 20 minutes to obtain a fumigation material, and water vapor is used to fumigate Folium Folium, Rhizoma Chuanxiong, and Bupleurum, wherein the water vapor temperature of the fumigation is at 100°C;
(3)将羚羊骨、黄芪、当归、丹参、细辛、茯苓、杜仲、厚朴、白芍、赤芍、甘草、蛇舌草依次添加到混料机中进行混合均匀,然后取出,得到混合料;(3) Add antelope bone, astragalus, angelica, salvia miltiorrhiza, asarum, poria cocos, eucommia ulmoides, magnolia officinalis, white peony root, red peony root, licorice root, and hedyotis into the mixer in order to mix evenly, and then take it out to obtain a mixed material;
(4)向上述得到的混合料中添加其质量10倍的清水,浸泡处理10min,然后再大伙煮至沸腾,再添加上述熏蒸料,搅拌均匀后,文火煎熬2小时,浸泡处理为常温下进行浸泡处理;(4) Add clear water 10 times its mass to the mixture obtained above, soak it for 10 minutes, then boil it until it boils, then add the above-mentioned fumigation material, stir evenly, simmer for 2 hours, and soak it at room temperature Soaking treatment;
(5)煎熬时间结束后,进行过滤,得到滤液;(5) After the decoction time ends, filter to obtain the filtrate;
(6)对滤液进行浓缩至原体积的50%,得到浓缩药液;(6) concentrating the filtrate to 50% of the original volume to obtain a concentrated medicinal solution;
(7)将黄芩进行粉碎,然后再用乙醇溶液对其进行回流搅拌2h,冷却至室温后继续搅拌12h,离心取上清液,黄芩与乙醇溶液混合的料液比为1:10;(7) Scutellaria baicalensis is pulverized, then it is refluxed and stirred with ethanol solution for 2 hours, after cooling to room temperature, continue to stir for 12 hours, and the supernatant is obtained by centrifugation. The solid-liquid ratio of Scutellaria baicalensis and ethanol solution is 1:10;
其中,所述乙醇溶液质量分数为70%;Wherein, the ethanol solution mass fraction is 70%;
(8)将上述得到的上清液装于摩尔质量为3500DA的透析袋中进行透析处理,透析得到的透析液进行喷雾干燥,得到混合提取物;(8) The supernatant obtained above is placed in a dialysis bag with a molar mass of 3500DA for dialysis treatment, and the dialysate obtained by the dialysis is spray-dried to obtain a mixed extract;
(9)将硫酸钠添加到盐酸溶液中,搅拌至溶解,再添加三氯乙酸和氯化钡,继续搅拌,得到处理液,硫酸钠、盐酸溶液混合质量比为1:25;(9) Add sodium sulfate to the hydrochloric acid solution, stir until dissolved, then add trichloroacetic acid and barium chloride, continue stirring to obtain a treatment solution, the mixing mass ratio of sodium sulfate and hydrochloric acid solution is 1:25;
所述盐酸溶液浓度为0.1mol/L;The concentration of the hydrochloric acid solution is 0.1mol/L;
盐酸溶液、三氯乙酸和氯化钡混合质量比为25:1:1;The mixing mass ratio of hydrochloric acid solution, trichloroacetic acid and barium chloride is 25:1:1;
(10)将混合提取物添加到处理液中,调节温度至50℃,保温搅拌反应1小时,得到反应液,对反应液进行调节pH至中性,然后再在摩尔质量为3500DA的透析袋中进行透析处理,透析得到的透析液进行喷雾干燥,得到药物配合剂;(10) Add the mixed extracts to the treatment solution, adjust the temperature to 50°C, heat and stir the reaction for 1 hour to obtain a reaction solution, adjust the pH of the reaction solution to neutral, and then place it in a dialysis bag with a molar mass of 3500DA Carry out dialysis treatment, and the dialysate obtained by dialysis is spray-dried to obtain a drug compound;
(11)将药物配合剂添加到浓缩药液中,搅拌均匀,即得。(11) Add the drug compound into the concentrated drug solution, stir evenly, and the product is ready.
选择年蛉在20~60岁,自愿且能够配合治疗慢性乙型肝炎245例,随机分成7组,每组35人,分别采用实施例与对比例中药组合物进行试验,对比:Choose 20~60 years old, voluntarily and can cooperate to treat 245 cases of chronic hepatitis B, divide into 7 groups at random, each group of 35 people, adopt embodiment and comparative example Chinese medicine composition to carry out test respectively, compare:
3治疗方法3 treatment methods
每天三次,每次用量为150ml,疗程共6个月;Three times a day, each dosage is 150ml, and the course of treatment is 6 months;
观察指标:Observation indicators:
临床症状和体征:乏力、食欲不振、肝区不适、轻度肝肿大或肝区叩击痛情况改善率。Clinical symptoms and signs: fatigue, loss of appetite, discomfort in the liver area, mild hepatomegaly or improvement rate of percussion pain in the liver area.
对实施例1与对比例各组的肝功能ALT、AST、TB、ALB各指标在治疗前后变化,取平均值:Each index of liver function ALT, AST, TB, ALB of each group of
表1Table 1
由表1可以看出,本发明制备的中药组合物能够大幅度的改善患者的乏力、食欲不振、肝区不适、轻度肝肿大或肝区叩击痛等情况;As can be seen from Table 1, the traditional Chinese medicine composition prepared by the present invention can greatly improve the patient's fatigue, loss of appetite, discomfort in the liver area, mild hepatomegaly or percussion pain in the liver area;
表2Table 2
由表2可以看出,本发明方法制备的中药组合物能够大幅度的改善肝功能ALT、AST、TB、ALB的指标。It can be seen from Table 2 that the traditional Chinese medicine composition prepared by the method of the present invention can greatly improve the indicators of liver function ALT, AST, TB, and ALB.
典型病例:Typical cases:
1陈某某,女,38岁,患者右胁部胀痛,食欲不振,体倦乏力,面黑无光,偶有后背牵涉,痛经,经过医院检查报告显示肝功能异常,肝大肋下1.8cm,被诊断为“慢性乙型肝炎”,就诊时症见:口干,口苦,口气较重,肋痛,乏力。1 Chen Moumou, female, 38 years old, the patient had distending pain in the right flank, loss of appetite, fatigue and fatigue, dark complexion, occasional involvement in the back, dysmenorrhea, and the hospital examination report showed abnormal liver function, hepatomegaly under the ribs 1.8cm, was diagnosed as "chronic hepatitis B", symptoms at the time of treatment: dry mouth, bitter mouth, heavy breath, rib pain, fatigue.
检查:面色黑黄,肝大肋下1.82cm,脾未触及,面色晦暗,舌暗红苔黄腻,脉弦数,肝功能检查为谷丙转氨酶600单位,乙型肝炎五项:HBsAg(+),anti-HBs(-),HBeAg(+),anti-HBe(-),anti-HBc(-)。Examination: complexion black and yellow, large liver and ribs 1.82cm below, spleen untouched, dull complexion, dark red tongue with yellow greasy coating, pulse strings and pulses, liver function test was alanine aminotransferase 600 units, five items of hepatitis B: HBsAg(+ ), anti-HBs(-), HBeAg(+), anti-HBe(-), anti-HBc(-).
辩证:慢性乙型肝炎活动期。Dialectical: active chronic hepatitis B.
治法:连续服用本发明中药,每次150ml,每天3次,连续6个月。Method for the treatment of: take Chinese medicine of the present invention continuously, each 150ml, every day 3 times, continuous 6 months.
疗效:经查各项肝功能指标恢复正常指标。Efficacy: After investigation, various liver function indicators returned to normal indicators.
图1为实施例与对比例临床症状和体征情况改善率柱状图。Fig. 1 is the histogram of the improvement rate of the clinical symptoms and signs of the embodiment and the comparative example.
对实施例与对比例治疗前后肝功能ALT的柱状图,如图2。尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。The histogram of the liver function ALT before and after treatment of the embodiment and the comparative example is shown in FIG. 2 . Although the embodiments of the present invention have been shown and described, those skilled in the art can understand that various changes, modifications and substitutions can be made to these embodiments without departing from the principle and spirit of the present invention. and modifications, the scope of the invention is defined by the appended claims and their equivalents.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211227606.XA CN115429839A (en) | 2022-10-09 | 2022-10-09 | A Chinese medicinal composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211227606.XA CN115429839A (en) | 2022-10-09 | 2022-10-09 | A Chinese medicinal composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115429839A true CN115429839A (en) | 2022-12-06 |
Family
ID=84251239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211227606.XA Pending CN115429839A (en) | 2022-10-09 | 2022-10-09 | A Chinese medicinal composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115429839A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101130008A (en) * | 2007-08-21 | 2008-02-27 | 王兴明 | Medicine, capsule for treating hepatitis B, and method of preparing the same |
| CN113456728A (en) * | 2021-08-02 | 2021-10-01 | 陈怀林 | A Chinese medicinal oral liquid for treating chronic hepatitis B, and its preparation method |
-
2022
- 2022-10-09 CN CN202211227606.XA patent/CN115429839A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101130008A (en) * | 2007-08-21 | 2008-02-27 | 王兴明 | Medicine, capsule for treating hepatitis B, and method of preparing the same |
| CN113456728A (en) * | 2021-08-02 | 2021-10-01 | 陈怀林 | A Chinese medicinal oral liquid for treating chronic hepatitis B, and its preparation method |
Non-Patent Citations (1)
| Title |
|---|
| 张永杰等: "《全国名中医张永杰临床经验集萃》", 上海科学技术出版社, pages: 114 - 122 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104189811A (en) | Traditional Chinese medicine composition for treating postpartum fainting and preparation method thereof | |
| CN112587640A (en) | Traditional Chinese medicine composition for relieving tumor cachexia | |
| CN1056064C (en) | Medicine for treating liver cancer and its preparing process | |
| CN104873926A (en) | Traditional Chinese medicine preparation for treating diarrhea as well as preparation method and application of traditional Chinese medicine preparation | |
| CN104758699A (en) | Preparation method of medicine for treating renal failure | |
| CN102949659A (en) | Traditional Chinese medicine composition for treating hepatitis B | |
| CN115429839A (en) | A Chinese medicinal composition | |
| CN114748603A (en) | A medicine and food homologous composition and application for preventing and treating new coronavirus pneumonia mutation or rejuvenation | |
| CN108339101A (en) | The preparation of the five internal organs function of warming yang and gore removing soft extract and the method for improving mouthfeel | |
| CN115487264A (en) | Composition for reducing phlegm and removing stasis and preparation method thereof | |
| CN109876127B (en) | Blood-nourishing angelica sinensis capsule and preparation method thereof | |
| CN113797298A (en) | Traditional Chinese medicine preparation for chronic hepatitis, preparation method and taking method thereof | |
| CN104840773A (en) | Traditional Chinese medicine composition for treating vertebral artery type cervical spondylopathy and method for preparing same | |
| CN112089809A (en) | Traditional Chinese medicine composition with spleen invigorating and qi benefiting functions, traditional Chinese medicine plaster and preparation method thereof | |
| CN104398975A (en) | Traditional Chinese medicinal preparation for treating fibroadenoma of breast and preparation method thereof | |
| CN102188656B (en) | Medicament for treating cold-dampness tracheitis and preparation method thereof | |
| CN102688401B (en) | Couchgrass root Chinese medicinal oral liquid for treating chronic hepatitis and preparation method thereof | |
| CN109078157A (en) | A kind of anti-tumor drug and preparation method thereof | |
| CN108671112B (en) | Traditional Chinese medicine composition for treating liver-stagnation and spleen-deficiency type autoimmune hepatitis and preparation method thereof | |
| CN107551175A (en) | One kind treats dyspeptic medicine of paediatrics and preparation method thereof | |
| CN118662585A (en) | Eucommia ulmoides granule for treating bone flaccidity and preparation method thereof | |
| CN111643617A (en) | Traditional Chinese medicine composition for conditioning and treating liver diseases and preparation method thereof | |
| CN121648212A (en) | A traditional Chinese medicine composition for warming yang, promoting blood circulation, and aiding growth, and its application. | |
| CN104306496A (en) | Heart and spleen tonifying preparation for rheumatic heart disease and preparation method thereof | |
| CN105106692A (en) | Traditional Chinese medicinal composition for gallstone postoperative recovery and preparation method of traditional Chinese medicinal composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221206 |
|
| RJ01 | Rejection of invention patent application after publication |

